Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

Adolescents with SCD often struggle with maintaining friendships, school performance, and participation in extracurricular ...

A Long Island hospital has successfully treated Sebastien Beauzile, a 21-year-old from Laurelton, with the groundbreaking ...

Researchers studied the efficacy of hydroxyurea at reducing stroke risk in sickle cell anemia, the most common and severe ...

Anyone living with sickle cell anemia is a warrior, Leslie Davis-Primo will tell you. “I’ve had three children, largely ...

A Shreveport-Bossier City musician is working tirelessly to better the quality of life for people like her sons, some of whom ...

A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...

Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its ...

MOROGORO: The provision of screening services for sickle cell Disease and diabetes type one in newborns has continued to be ...

Columnist Oluwatosin Adesoye shares how she processes her emotions when she's feeling guilty about the care she needs due to sickle cell.

Zydus Lifesciences Ltd on Wednesday (March 12) the company's venture capital arm Zynext Ventures USA LLC has announced an ...